BALCX | ETIMX | BALCX / ETIMX | |
Total Expense Ratio | 1.31 | 0.82 | 160% |
Annual Report Gross Expense Ratio | 1.31 | 0.89 | 147% |
Fund Existence | 25 years | 10 years | - |
Gain YTD | 13.865 | 7.212 | 192% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 100000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 266B | 392M | 67,857% |
Annual Yield % from dividends | 1.12 | 2.03 | 55% |
Returns for 1 year | 7.92 | 3.50 | 227% |
Returns for 3 years | 48.39 | 36.77 | 132% |
Returns for 5 years | 37.66 | 30.50 | 123% |
Returns for 10 years | 67.51 | 90.34 | 75% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JAGLX | 74.71 | 0.50 | +0.67% |
Janus Henderson Global Life Sciences T | |||
MSTGX | 9.92 | N/A | N/A |
Morningstar Global Income | |||
AFMBX | 38.96 | -0.06 | -0.15% |
American Funds American Balanced F3 | |||
VLLIX | 49.24 | -0.35 | -0.71% |
Value Line Larger Companies Focus Instl | |||
HRLVX | 22.80 | -0.25 | -1.08% |
Harbor Large Cap Value Admin |